GL1X · GenesisL1 explorer

Research workbench

E. COLI enoyl reductase in complex with NAD and SB611113

Analyse E. COLI enoyl reductase in complex with NAD and SB611113 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1MFP
Type
protein
Length
516 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Enoyl-[acyl-carrier-protein] reductase [NADH]
EC
1.3.1.9
UniProt
P29132
Ligands
NAD, IDN, SO4
Pockets
5 · best druggability 0.80

Structure

x-ray diffraction · 1 distinct chain · 49% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BEnoyl-[acyl-carrier-protein] reductase [NADH] (EC 1.3.1.9)protein25849% helix, 14% strandP29132

Ligands and binding sites

  • NAD · Nicotinamide-adenine-dinucleotide · ligand · 2 copies · chains A, B
  • IDN · (E)-N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-[1,8]naphthyridin-3-yl)-acrylamide · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15810.800.8649NAD, IDN
25900.800.8652NAD, IDN
3970.410.7725empty
4860.400.7812empty
5720.330.7512empty

Interfaces

1 interface between chains.

  • A–B · 1716 Ų buried · 47 hydrogen bonds · protein-protein

Compared structures

  • 1MFP · E. coli Enoyl Reductase in complex with NAD and SB611113 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.